Sunthetics

United States
Greenfield, Tennessee, United States, 78666

Company profile

Sunthetics company profile

Sunthetics enables process chemists in pharma to develop electrochemical lead molecules in 1/10th of the time. Electrochemistry has many operational, cost, and sustainable benefits such as using 40% less energy, avoiding toxic chemicals and waste, and enabling new types of molecules. Despite interest in pharmaceuticals to develop electrochemical molecules, many molecules don't make it past process development. For most applications, the many years of optimization and additional training required don't justify the energy and cost savings. Sunthetics develops smart electrochemical reactors that enable process chemists to develop at-scale processes in 1/10th of the time. Our effective hardware is scalable and effective, and enables fast results through a machine-learning platform that is automatic and predictive, reducing the experiments needed for development by 10x. Though the beachhead market is pharmaceuticals, Sunthetics has a platform technology that can be scaled and applied to follow-on markets such as agrochemicals and specialty chemicals, spearheading the electrification of the chemical industry.

Business identity

Contact email
[email protected]
Operating status
Active
Company type
For Profit
Employee range
1-10 employees
Revenue range
$0+
Founded
2018-01-01, Year

Headquarters

Postal code
78666
Country code
US
Continent
North America

Capital profile

Funding and company signals

Funding stage
Seed
Funding rounds
8
Total equity funding
$5.1M
Last funding
Seed / $4M / 2024-11-13
Last equity funding
Seed / $4M
Investors
11
Lead investors
4
Founders
3
Articles
5

Founders and investors

Founders

Daniela BlancoMiguel ModestinoMyriam Sbeiti

Lead investors

Cleantech OpenL'ATTITUDE VenturesNational Science FoundationTechstars

Investors

L'ATTITUDE VenturesNational Science FoundationREFASHIOND VenturesS3 VenturesTechstars